Literature DB >> 11562543

Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype.

D Paraskevis1, E Magiorkinis1, G Magiorkinis1, C Anastassopoulou1, M Lazanas2, G Chrysos3, A M Vandamme4, A Hatzakis1.   

Abstract

Recombination is one of several factors that contribute to the great genetic diversity of human immunodeficiency virus type 1 (HIV-1). In the current study, analysis of the full-length genome of a novel complex mosaic HIV-1 isolate (99GR303) from a Greek sailor who was possibly infected in Sierra Leone, Africa is presented. The 99GR303 isolate was found to comprise genomic regions belonging to subtypes A, G, J and K as well as of regions of a subtype that remains unclassified. For a partial region of env as well as vpr, no apparent similarity to the known HIV-1 subtypes or to any of the circulating recombinant forms was found. In fact, in the partial env gene, including the C2-V3 region, the 99GR303 isolate formed a new clade, suggesting the existence of an additional HIV-1 subtype. Thus, novel recombinants embody partial genomic regions which may have originated either from subtypes that existed in the past and became extinct or from contemporary subtypes that are extremely rare.

Entities:  

Mesh:

Year:  2001        PMID: 11562543     DOI: 10.1099/0022-1317-82-10-2509

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  2 in total

1.  Use of sequence data generated in the Bayer Tru Gene genotyping assay to recognize and characterize non-subtype-b human immunodeficiency virus type 1 strains.

Authors:  Diane L Hirigoyen; Charles P Cartwright
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Prevalence of drug resistance mutations among ART-naive and -experienced HIV-infected patients in Sierra Leone.

Authors:  George A Yendewa; Foday Sahr; Sulaiman Lakoh; Marta Ruiz; Lucia Patiño; Andrés Tabernilla; Gibrilla F Deen; Momodu Sesay; Robert A Salata; Eva Poveda
Journal:  J Antimicrob Chemother       Date:  2019-07-01       Impact factor: 5.790

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.